|
1
|
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2003
|
3.96
|
|
2
|
Differentiation of reinfection from relapse in recurrent Lyme disease.
|
N Engl J Med
|
2012
|
3.79
|
|
3
|
Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
|
Ann Intern Med
|
2002
|
3.41
|
|
4
|
Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease.
|
Am J Med
|
2003
|
3.23
|
|
5
|
Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.
|
Clin Infect Dis
|
2005
|
3.04
|
|
6
|
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.
|
J Infect Dis
|
2008
|
2.26
|
|
7
|
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans.
|
Am J Trop Med Hyg
|
2008
|
1.82
|
|
8
|
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.
|
J Antimicrob Chemother
|
2010
|
1.75
|
|
9
|
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
|
Diagn Microbiol Infect Dis
|
2012
|
1.45
|
|
10
|
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings.
|
J Clin Microbiol
|
2002
|
1.40
|
|
11
|
Brief communication: hematogenous dissemination in early Lyme disease.
|
Ann Intern Med
|
2005
|
1.24
|
|
12
|
Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
|
Clin Infect Dis
|
2010
|
1.20
|
|
13
|
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.
|
Diagn Microbiol Infect Dis
|
2012
|
1.10
|
|
14
|
Microbiologic evaluation of patients from Missouri with erythema migrans.
|
Clin Infect Dis
|
2005
|
1.10
|
|
15
|
Asymptomatic infection with Borrelia burgdorferi.
|
Clin Infect Dis
|
2003
|
1.08
|
|
16
|
Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.
|
Clin Vaccine Immunol
|
2008
|
1.08
|
|
17
|
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.
|
Clin Diagn Lab Immunol
|
2005
|
0.99
|
|
18
|
Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii.
|
Vector Borne Zoonotic Dis
|
2011
|
0.92
|
|
19
|
Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease.
|
Arthritis Rheumatol
|
2014
|
0.89
|
|
20
|
Evidence for strain-specific immunity in patients treated for early lyme disease.
|
Infect Immun
|
2014
|
0.82
|
|
21
|
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population.
|
J Am Acad Nurse Pract
|
2004
|
0.82
|
|
22
|
Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.
|
J Clin Microbiol
|
2013
|
0.82
|
|
23
|
Duration of treatment for Lyme borreliosis: time for a critical reappraisal.
|
Wien Klin Wochenschr
|
2002
|
0.75
|